戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 gen II expression predicts poor prognosis in high-grade serous ovarian carcinoma.
2 y considered the dominant site of origin for high-grade serous ovarian carcinoma.
3 cretory cells that are the site of origin of high-grade serous ovarian carcinomas.
4 d in fallopian tube carcinomas compared with high-grade serous ovarian carcinomas.
5 cription factor FOXO3a in a vast majority of high-grade serous ovarian carcinomas.
6    Because of the high risk of recurrence in high-grade serous ovarian carcinoma (HGS-OvCa), the deve
7                                              High-grade serous ovarian carcinoma (HGSOC) and basal-li
8                                              High-grade serous ovarian carcinoma (HGSOC) is a lethal
9                             A key feature of high-grade serous ovarian carcinoma (HGSOC) is frequent
10                                              High-grade serous ovarian carcinoma (HGSOC) is the most
11                                              High-grade serous ovarian carcinoma (HGSOC) is the most
12                                              High-grade serous ovarian carcinoma (HGSOC), the most le
13 tic TP53 mutations are a defining feature of high-grade serous ovarian carcinoma (HGSOC).
14 cer cell lines and in organoids derived from high-grade serous ovarian carcinomas (HGSOC), an aggress
15  present in peritoneal fluid from women with high-grade serous ovarian carcinomas (HGSOCs).
16 y discriminated an independent cohort of 226 high-grade serous ovarian carcinomas into groups of high
17                                              High-grade serous ovarian carcinoma presents significant
18                       Until fairly recently, high-grade serous ovarian carcinoma seemed to be one of
19 the genomic aberrations to those observed in high-grade serous ovarian carcinomas suggests that genet
20  a paradigm for the origin and initiation of high-grade serous ovarian carcinomas, the most common an
21 ification as a candidate oncogenic driver in high-grade serous ovarian carcinoma, we evaluated the fu

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。